Receptors in neurodegenerative diseases, muscarinic cholinergic receptors

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 131-134

  Angeli, Piero ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Muscarinic receptor subtype characterization; Muscarinic therapeutic agents; Selective muscarinic receptor antagonist

Indexed keywords

3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; [4 [(3 CHLOROPHENYL)CARBAMOYLOXY] 2 BUTYNYL]TRIMETHYLAMMONIUM; G PROTEIN COUPLED RECEPTOR; GALLAMINE; HEXAHYDROSILADIFENIDOL; MEMBRANE RECEPTOR; METHOCTRAMINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; OTENZEPAD; PIRENZEPINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BINDING SITE; CENTRAL NERVOUS SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; DEGENERATIVE DISEASE; HUMAN; IRRITABLE COLON; MUTATION; NONHUMAN; PARKINSON DISEASE; PROTEIN DOMAIN; PROTEIN STRUCTURE; RECEPTOR BINDING; URINE INCONTINENCE;

ANIMALS; HUMANS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NEURODEGENERATIVE DISEASES; RECEPTORS, MUSCARINIC;

EID: 0034112947     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00025-4     Document Type: Conference Paper

References (22)

1. Adem A., Karlsson E. Muscarinic receptor subtype selective toxins. Life Sci. 60:1997;1069-1076.
2. 4 antagonists for clinical use. Life Sci. 60:1997;1053-1060.
3. Anwar-ul S., Gilani H., Cobbin L.B. The cardio-selectivity of himbacine: a muscarine receptor antagonist. Naunyn-Schmiedegerg's Arch. Pharmacol. 332:1986;16-20.
4. 4 selective muscarinic antagonists. Life Sci. 60:1997;1168.
5. Barlow R.B., Berry K.J., Glenton P.A.M., Nikolaou N.M., Soh K.S. A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29°C and 37°C. Br. J. Pharmacol. 58:1976;613-620.
6. Eberlein, W.G., Engel, W., Mihm, G., Rudolf, K., Wetzel, B., Entzeroth, M., Mayer, N., Doods, H.N., 1989. Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinic. TIPS, Suppl. 50-54.
7. Gilbert R., Rattan S., Goyal R.K. Pharmacologic identification, activation and antagonism of two muscarinic sensitive receptor subtypes in the lower oesophageal sphincter. J. Pharmacol. Exp. Ther. 230:1984;284-291.
8. 2. Biochemical and functional characterization. Life Sci. 31:1982;2991-2994.
9. Hammer R., Berrie C.P., Birdsall N.J.M., Burgen A.S.V., Hulme E.C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature. 283:1980;90-92.
10. Hammer R., Giraldo E., Schiavi G.B., Monferini E., Ladinsky H. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci. 38:1986;1653-1662.
11. Jerusalinsky D., Harvey A.L. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. TIPS. 15:1994;424-430.
12. Kubo T., Fukuda K., Mikami A., Maeda A., Takahashi H., Mishina M., Haga T., Haga K., Ichiyama A., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 323:1986;411-416.
13. Lambrecht, G., Feifel, R., Moser, U., Wagner-Röder, M., Choo, L.K., Camus, J., Tastenoy, M., Waelbroeck, M., Strohmann, C., Tacke, R., Rodrigues de Miranda, J.F., Christophe, J., Mutschler, E., 1989. Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol and related selective muscarinic antagonists. TIPS, Suppl. 60-64.
14. Melchiorre C., Cassinelli A., Quaglia W. Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors. J. Med. Chem. 30:1987;201-204.
15. Micheletti R., Schiavone A., Angelici O., Duranti P., Giudici L., Cereda E., Donetti A. Affinity profile of the novel muscarinic antagonist, guanylpirenzepine. Life Sci. 47:1990;PL55-PL58.
16. Minarini A., Bolognesi M.L., Budriesi R., Canossa M., Chiarini A., Spampinato S., Melchiorre C. Design, synthesis and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines. J. Med. Chem. 37:1994;3363-3372.
17. Mutschler, E., Lambrecht, G., 1984. Selective muscarinic agonists and antagonists in functional tests. TIPS, Suppl. 39-44.
18. Riker W.F., Wescoe W.C. The pharmacology of flaxedil with observations on certain analogs. Ann. N.Y. Acad. Sci. 54:1951;373-394.
19. Roszkowski A.P. An unusual type of sympathetic ganglionic stimulant. J. Pharmacol. Exp. Ther. 132:1961;156-170.
20. TIPS, 1984. Supplement (January).
21. TIPS, 1989. Supplement (December).
22. Wess J. Molecular basis of muscarinic acetylcholine receptor function. TIPS. 14:1993;308-313.